Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors

Abstract excerpt

Vaccines and drugs have helped reduce disease severity and blunt the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, ongoing virus transmission, continuous evolution, and increasing selective pressures have the potential to yield viral variants capable of resisting these interventions. Here, we investigate the susceptibility of natural variants of the main protease [M pro ;...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Mosquito-borne diseases and control
• Share to SARS-CoV-2 and COVID-19 Research
• Share to vaccines and immunoinformatics approaches